These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26385607)

  • 1. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
    Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MART-10, a 1α,25(OH)
    Chiang KC; Yeh CN; Yeh TS; Juang HH; Chen LW; Kuo SF; Chen MH; Chen TC; Takano M; Kittaka A; Pang JS
    Anticancer Res; 2018 Jul; 38(7):3879-3887. PubMed ID: 29970508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
    Chiang KC; Kuo SF; Chen CH; Ng S; Lin SF; Yeh CN; Chen LW; Takano M; Chen TC; Juang HH; Kittaka A; Lin JD; Pang JH
    Cancer Lett; 2015 Dec; 369(1):76-85. PubMed ID: 26282787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1α,25(OH)
    Chiang KC; Yeh CN; Pang JS; Hsu JT; Yeh TS; Chen LW; Kuo SF; Takano M; Chen TC; Kittaka A; Hsieh PJ; Juang HH
    Anticancer Res; 2017 Nov; 37(11):6215-6221. PubMed ID: 29061804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
    Yang SW; Tsai CY; Pan YC; Yeh CN; Pang JH; Takano M; Kittaka A; Juang HH; Chen TC; Chiang KC
    Drug Des Devel Ther; 2016; 10():1995-2002. PubMed ID: 27382252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
    Chiang KC; Yeh TS; Huang CC; Chang YC; Juang HH; Cheng CT; Pang JS; Hsu JT; Takano M; Chen TC; Kittaka A; Hsiao M; Yeh CN
    Sci Rep; 2017 Mar; 7():43773. PubMed ID: 28256614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
    Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
    Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
    Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo.
    Zhao K; Yuan Y; Lin B; Miao Z; Li Z; Guo Q; Lu N
    Gene; 2018 Feb; 642():533-541. PubMed ID: 29196258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.
    Chiang KC; Yeh CN; Hsu JT; Jan YY; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Chen WT; Pang JH; Yeh TS; Juang HH
    Cancer Lett; 2014 Nov; 354(2):235-44. PubMed ID: 25149065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
    Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.
    Chiang KC; Yeh CN; Hsu JT; Yeh TS; Jan YY; Wu CT; Chen HY; Jwo SC; Takano M; Kittaka A; Juang HH; Chen TC
    Cell Cycle; 2013 Apr; 12(8):1316-25. PubMed ID: 23549173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
    Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
    J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.
    Xing Y; Tu J; Zheng L; Guo L; Xi T
    Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.